1-16 of 16
Juan Li, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Runx2 Deficiency in Committed Osteoblasts Promotes Myeloma Cell Homing to and Progression in New Bone Sites

Xiaoxuan Xu, Juan Li, MD, Timothy Trotter, Pramod Gowda, Xiaoxiao Hao, Jacob Calahan, Racquel Innis-Shelton, MD, Amjad Javed, Yang Yang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 126.
https://doi.org/10.1182/blood.V130.Suppl_1.126.126
Published: 2017
Journal Articles

Scoring System for Predicting Risk of Relapse in Patients with Multiple Myeloma within Two Years after Stem Cell Transplantation

Beihui Huang, MD, Juan Li, MD, Jin Lu, MD, Yang Xiao, MD, Ying Zhao, MD, Hongming Huang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4531.
https://doi.org/10.1182/blood.V130.Suppl_1.4531.4531
Published: 2017
Journal Articles

Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

Beihui Huang, MD, Juan Li, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4532.
https://doi.org/10.1182/blood.V130.Suppl_1.4532.4532
Published: 2017
Journal Articles

a Proposal for a New Staging System of Extranodal Natural Killer T-cell Lymphoma, Nasal-Type: a Multicenter Study of Chinese Southwest Oncology Group (CSWOG)

Huangming Hong, MD, Xin Du, MD, Mingzhi Zhang, MD, Jinghua Wang, PhD, Jun Zhu, MD, He Huang, MD, Ting Liu, MD, Fanyi Meng, Gang Wu, Ye Guo, Weili Zhao, Jie Jin, MD, Juan Li, MD PhD, Yanming Deng, Kangsheng Gu, Xiangyuan Wu, Xiaoyan Ke, MD PhD, Derong Xie, Daren Lin, Tongyu Lin, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4444.
https://doi.org/10.1182/blood.V124.21.4444.4444
Published: 2014
Journal Articles

Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

Beihui Huang, M.D., Juan Li, MD, PhD, Junru Liu, M.D., Dong Zheng, MD, PhD, Mei Chen, M.D., Zhenhai Zhou, M.D., Duorong Xu, M.D., Waiyi Zou, M.D.
Journal: Blood
Blood (2012) 120 (21): 5036.
https://doi.org/10.1182/blood.V120.21.5036.5036
Published: 2012
Journal Articles

Hypophosphorylated Retinoic Acid Receptor Alpha Inhibits the Proliferation of Multiple Myeloma Cells

Dong Zheng, MD, PhD, Juan Li, MD, PhD, Guo Xiaojuan, M.D., Zheng Chaoxu, M.D., Zhang Longjuan, M.D.
Journal: Blood
Blood (2012) 120 (21): 4990.
https://doi.org/10.1182/blood.V120.21.4990.4990
Published: 2012
Journal Articles

Clinical Experience and Prognostic Factors with Bortezomib-Combined Regimen in 40 Patients with Multiple Myeloma

Juan Li, MD, PhD, Ying Zhao
Journal: Blood
Blood (2008) 112 (11): 5211.
https://doi.org/10.1182/blood.V112.11.5211.5211
Published: 2008
Journal Articles

The Clinical Study of Combination of Bortezomib and Dexamethasone in Treatment of Newly Diagnosed Multiple Myeloma

Juan Li, MD, PhD, Lijin Zeng
Journal: Blood
Blood (2008) 112 (11): 5217.
https://doi.org/10.1182/blood.V112.11.5217.5217
Published: 2008
Journal Articles

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Yang Shen, MD, Zhixiang Shen, MD, Bin Jiang, MD, Jian Hou, MD, Rong Zhan, MD, Lugui Qiu, MD, Yongji Wu, MD, Jie Jin, MD, Juan Li, MD, Fanyi Meng, MD, Ping Zou, MD, Ting Liu, MD, Jianyong Li, MD, Chun Wang, MD, Depai Wu, MD, Jun Ma, MD
Journal: Blood
Blood (2007) 110 (11): 4816.
https://doi.org/10.1182/blood.V110.11.4816.4816
Published: 2007
Journal Articles

Safety and Efficacy of Bortezomib and Dexamethasone (BD) in Multiple Myeloma as First-Line, Second-Line or Third-Line Treatment.

Juan Li, MD, Beihui Huang, MD, Ying Zhao, MD, Dong Zheng, MD, Shaokai Luo, MD
Journal: Blood
Blood (2007) 110 (11): 4817.
https://doi.org/10.1182/blood.V110.11.4817.4817
Published: 2007
Journal Articles

Imatinib Induces Apoptosis of Myeloma Cells by Inhibiting c-Kit Signaling Transduction.

Juan Li, MD, Beihui Huang, MD, Ying Zhao, MD, Shaokai Luo, MD
Journal: Blood
Blood (2007) 110 (11): 4738.
https://doi.org/10.1182/blood.V110.11.4738.4738
Published: 2007
Journal Articles

Expression and Clinical Significance of β-Catenin in Multiple Myeloma.

Juan Li, MD, Dian-Bao Zhang, MD, Shao-kai Luo, MD, Ying Zhao, MD, Bei-Hui Huang, MD, Jing-Li Gu, MD
Journal: Blood
Blood (2006) 108 (11): 5010.
https://doi.org/10.1182/blood.V108.11.5010.5010
Published: 2006
Journal Articles

The Research of Specific Inhibition of Survivin Expression To Reverse Drug Resistance with RNA Interference Technology.

Juan Li, MD, Ying Zhao, MD, Shao-kai Luo, MD, Dian-bao Zhang, MD, Bei-hui Haung, MD
Journal: Blood
Blood (2005) 106 (11): 5065.
https://doi.org/10.1182/blood.V106.11.5065.5065
Published: 2005
Journal Articles

The Expression and Clinical Significance of Survivin in Multiple Myeloma.

Juan Li, MD, Ying Zhao, MD, Dian-Bao Zhang, MD, Bei-Hu Haung, MD
Journal: Blood
Blood (2005) 106 (11): 5066.
https://doi.org/10.1182/blood.V106.11.5066.5066
Published: 2005
Journal Articles

Expression of the CD 117 Antigen on Multiple Myeloma and Its Significance.

Juan Li, MD, Shaokai Luo, MD, Guocai Zhang, MD, Wende Hong, MD, Xiuzhen Tong, MD
Journal: Blood
Blood (2004) 104 (11): 4867.
https://doi.org/10.1182/blood.V104.11.4867.4867
Published: 2004
Journal Articles

Expression of TRAIL Receptors on the Multiple Myeloma Cells.

Juan Li, MD, Junhe Li, MD, Shaokai Luo, MD, Yin Zhao, MD
Journal: Blood
Blood (2004) 104 (11): 4868.
https://doi.org/10.1182/blood.V104.11.4868.4868
Published: 2004